Navigation Links
InterMune to Release Second Quarter 2008 Financial Results and Provide Business Update on July 31
Date:7/24/2008

BRISBANE, Calif., July 24 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) announced today that it will release second quarter 2008 financial results and provide a business update on Thursday, July 31, 2008 at 4:00 p.m. Eastern time. A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day.

To access the live teleconference, dial 888-799-0528 (U.S.) or 706-634-0154 (international), conference ID# 57393097. To access the webcast, please log on to the company's website at http://www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

A replay of the webcast and teleconference will be available approximately three hours after the call. The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 57393097.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a research and development portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research progr
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. InterMune to Present at Jefferies Healthcare Conference
2. InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences
3. InterMune to Present at Citigroup Healthcare Conference
4. InterMune to Present at Bank of America Health Care Conference
5. InterMune to Present at Deutsche Bank Health Care Conference
6. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
7. Evotec Expands Collaboration With InterMune
8. InterMune to Present at the SIGnificant Options in Healthcare Conference
9. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
10. InterMune Announces Closing of Public Offering of Common Stock
11. InterMune Announces Pricing of $68 Million Public Offering of Common Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...lth care employment grew by 29,000 jobs in Octobe...istent growth during the U.S. recession. However, ... and health systems are coming closer to having to...dministrators. , (Vocus) ...ued growing in October despite the shedding of job...
(Date:11/24/2009)...if., Nov. 24 NeurogesX, ... focused on developing and commercializing novel p...hony DiTonno, President and Chief Executive Office...r Jaffray Health Care Conference, to be held Decem...York, New York. ,, Mr. DiTonno and Stephen Ghi...
(Date:11/24/2009)...FBI recently approved the Promega PowerPlex 16 HS ... generating DNA records for the National DNA Index...A (PRWEB) -- The FBI recently approved the Promega...ries participating in, or generating DNA records f...rently contains more than seven million profiles a...
(Date:11/24/2009)...ber 24 Shire plc (LSE: S...maceutical company, today,announced that it has su...,velaglucerase alfa, the company,s enzyme replacem...pe 1 Gaucher disease. This is the third marketing,...ubmitted, with previous,submissions in the United ...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...18 PharmAthene, Inc.,(Amex: PIP ), a biodefense ... biological and chemical threats, announced today ...ions and an oral presentation on its,Protexia(R) a... the,upcoming HHS Public Health Emergency Medical ...orkshop 2008 / BARDA Industry Day, being held in,A...
... CJPS Enterprises, LLC, the,operator of the Michig...inar schedule available to Michigan companies inte...nd best practices in the healthcare,industry. CJPS...m ) was assigned,this activity by the Michigan Eco...e Life Sciences Pipeline initiative, which was cre...
...18 Human Genome,Sciences, Inc. (Nasdaq: HGSI ) a...obal Life Sciences Conference will be webcast and ... http://www.newscom.com/cgi-bin/prnh/20080416/HGSL... management team will present,a corporate overview...,Time., Investors interested in listening to the ...
Other Biology Technology:PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008 2The Michigan Life Sciences Pipeline Announces New Best Practices Seminars Tailored to Michigan Businesses 2
(Date:11/25/2009)...lif.Scientists at the California Institute of Tech...itive emotion-like behavior in the fruit fly, Dro...ay be relevant to the relationship between the neu...activity disorder (ADHD), are described in the Dec...ophila brain contains only about 20,000 neurons a...
(Date:11/25/2009)...Larisch, Head of the Cell Death Research Laborator...gy, has been awarded the prestigious Johnson & Joh...ing the cause of brain cell damage in Parkinson,s ...scientists in support of innovation and excellence... conferred earlier this month at an event at the H...
(Date:11/25/2009)...CAWhen you eat may be just as vital to your health...stitute for Biological Studies. Their experiments ...of thousands of genes in the liverthe body,s metab...ake and not by the body,s circadian clock as conve...mines the activity of a large number of genes comp...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Feeding the clock 2Feeding the clock 3Sorafenib significantly improves the length of time before breast cancer worsens 58117 1Sorafenib significantly improves the length of time before breast cancer worsens 58117 2World Heart Day 27 September 2009 Work With Heart 58116 1World Heart Day 27 September 2009 Work With Heart 58116 2World Heart Day 27 September 2009 Work With Heart 58116 3World Heart Day 27 September 2009 Work With Heart 58116 4World Heart Day 27 September 2009 Work With Heart 58116 5World Heart Day 27 September 2009 Work With Heart 58116 6First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 1First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 2
...available in German . , Since Monday of this ...inical phase I trial in Neuss, Germany, where it i...PM1002 is based on a vaccine that has been in use ... prevent infection with tuberculosis bacteria much...entific basis for this was laid down by the team w...
...the Environment provides strong evidence that com... costs. The author, Yoram Krozer, General Director...niversities, Institute for Sustainable Innovations...r-reaching, emissions-reduction percentage--as muc... by policy-makers and market interests. , Using ...
... September 11, 2008 People who are asked whether ...d" snack might not follow their intentions when th...tober 2008 issue of the Journal of Nutrition Educ...there is a substantial inconsistency between healt... , Participants were asked about their intentions...
Other Biology News:Clinical trial for new tuberculosis vaccine 2Improving industry efficiency through environmental innovations 2Making snack food choices 2
SuperScript III RNase H- Reverse Transcriptase from Invitrogen
Rabbit Anti-Versican (H-56) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
... incubator for cell and tissue cultures, including...perature. HERAcell incubators are specifically des...grow your valuable samples: , , Safe and stable i.... , ContraCon 90 C decontamination routine decont...
...s Directed Auto Purification software, a web-based...for automated compound isolation and purification ...programs. The system has been designed specificall...urification for synthetic chemists using a simple,...
Biology Products: